BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35985817)

  • 1. Netrin G1 Is a Novel Target Antigen in Primary Membranous Nephropathy.
    Reinhard L; Machalitza M; Wiech T; Gröne HJ; Lassé M; Rinschen MM; Ferru N; Bräsen JH; Drömann F; Rob PM; Sethi S; Hoxha E; Stahl RAK
    J Am Soc Nephrol; 2022 Oct; 33(10):1823-1831. PubMed ID: 35985817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigen-Specific IgG Subclasses in Primary and Malignancy-Associated Membranous Nephropathy.
    von Haxthausen F; Reinhard L; Pinnschmidt HO; Rink M; Soave A; Hoxha E; Stahl RAK
    Front Immunol; 2018; 9():3035. PubMed ID: 30619370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical and serological characterization of membranous nephropathy in children and adolescents.
    Dettmar AK; Wiech T; Kemper MJ; Soave A; Rink M; Oh J; Stahl RAK; Hoxha E;
    Pediatr Nephrol; 2018 Mar; 33(3):463-472. PubMed ID: 29034405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contactin-1 is a novel target antigen in membranous nephropathy associated with chronic inflammatory demyelinating polyneuropathy.
    Le Quintrec M; Teisseyre M; Bec N; Delmont E; Szwarc I; Perrochia H; Machet MC; Chauvin A; Mavroudakis N; Taieb G; Lanfranco L; Rigothier C; José B; Concetta C; Geneste C; Pernin V; Larroque C; Devaux J; Beyze A
    Kidney Int; 2021 Dec; 100(6):1240-1249. PubMed ID: 34600965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membranous nephropathy: new pathogenic mechanisms and their clinical implications.
    Hoxha E; Reinhard L; Stahl RAK
    Nat Rev Nephrol; 2022 Jul; 18(7):466-478. PubMed ID: 35484394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of membranous nephropathy recurrence after transplantation by monitoring of anti-PLA2R1 (M-type phospholipase A2 receptor) autoantibodies: a case series of 15 patients.
    Seitz-Polski B; Payré C; Ambrosetti D; Albano L; Cassuto-Viguier E; Berguignat M; Jeribi A; Thouret MC; Bernard G; Benzaken S; Lambeau G; Esnault VL
    Nephrol Dial Transplant; 2014 Dec; 29(12):2334-42. PubMed ID: 25063424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Podocyte Antigen Staining to Identify Distinct Phenotypes and Outcomes in Membranous Nephropathy: A Retrospective Multicenter Cohort Study.
    Hanset N; Aydin S; Demoulin N; Cosyns JP; Castanares-Zapatero D; Crott R; Cambier JF; Pochet JM; Gillerot G; Reginster F; Houssiau F; Debiec H; Ronco P; Jadoul M; Morelle J;
    Am J Kidney Dis; 2020 Nov; 76(5):624-635. PubMed ID: 32668319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal expression of PLA2R, THSD7A, and IgG4 in patients with membranous nephropathy and correlation with clinical findings.
    Kaya B; Paydas S; Balal M; Eren Erdogan K; Gonlusen G
    Int J Clin Pract; 2021 Apr; 75(4):e13855. PubMed ID: 33249733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy.
    Tomas NM; Beck LH; Meyer-Schwesinger C; Seitz-Polski B; Ma H; Zahner G; Dolla G; Hoxha E; Helmchen U; Dabert-Gay AS; Debayle D; Merchant M; Klein J; Salant DJ; Stahl RAK; Lambeau G
    N Engl J Med; 2014 Dec; 371(24):2277-2287. PubMed ID: 25394321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membranous Nephropathy and Anti-Podocytes Antibodies: Implications for the Diagnostic Workup and Disease Management.
    Pozdzik A; Brochériou I; David C; Touzani F; Goujon JM; Wissing KM
    Biomed Res Int; 2018; 2018():6281054. PubMed ID: 29511687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Alternative Pathway Is Necessary and Sufficient for Complement Activation by Anti-THSD7A Autoantibodies, Which Are Predominantly IgG4 in Membranous Nephropathy.
    Manral P; Caza TN; Storey AJ; Beck LH; Borza DB
    Front Immunol; 2022; 13():952235. PubMed ID: 35874690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel ELISA for thrombospondin type 1 domain-containing 7A autoantibodies in membranous nephropathy.
    Zaghrini C; Seitz-Polski B; Justino J; Dolla G; Payré C; Jourde-Chiche N; Van de Logt AE; Booth C; Rigby E; Lonnbro-Widgren J; Nystrom J; Mariat C; Cui Z; Wetzels JFM; Ghiggeri G; Beck LH; Ronco P; Debiec H; Lambeau G
    Kidney Int; 2019 Mar; 95(3):666-679. PubMed ID: 30784662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating antibodies to α-enolase and phospholipase A
    Kimura Y; Miura N; Debiec H; Morita H; Yamada H; Banno S; Ronco P; Imai H
    Clin Exp Nephrol; 2017 Feb; 21(1):117-126. PubMed ID: 26830547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contactin 1, a Potential New Antigen Target in Membranous Nephropathy: A Case Report.
    Santoro D; Debiec H; Longhitano E; Torreggiani M; Barreca A; Vegezzi E; Mazzeo A; Russo M; Piccoli GB; Toscano A; Ronco P
    Am J Kidney Dis; 2022 Aug; 80(2):289-294. PubMed ID: 34762973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies against thrombospondin type 1 domain-containing 7A induce membranous nephropathy.
    Tomas NM; Hoxha E; Reinicke AT; Fester L; Helmchen U; Gerth J; Bachmann F; Budde K; Koch-Nolte F; Zahner G; Rune G; Lambeau G; Meyer-Schwesinger C; Stahl RA
    J Clin Invest; 2016 Jul; 126(7):2519-32. PubMed ID: 27214550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-Autoantibody Signature and Clinical Outcome in Membranous Nephropathy.
    Ghiggeri GM; Seitz-Polski B; Justino J; Zaghrini C; Payré C; Brglez V; Dolla G; Sinico A; Scolari F; Vaglio A; Prunotto M; Candiano G; Radice A; Bruschi M; Lambeau G;
    Clin J Am Soc Nephrol; 2020 Dec; 15(12):1762-1776. PubMed ID: 33257410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy.
    Beck LH; Bonegio RG; Lambeau G; Beck DM; Powell DW; Cummins TD; Klein JB; Salant DJ
    N Engl J Med; 2009 Jul; 361(1):11-21. PubMed ID: 19571279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating Antibodies against Thrombospondin Type-I Domain-Containing 7A in Chinese Patients with Idiopathic Membranous Nephropathy.
    Wang J; Cui Z; Lu J; Probst C; Zhang YM; Wang X; Qu Z; Wang F; Meng LQ; Cheng XY; Liu G; Debiec H; Ronco P; Zhao MH
    Clin J Am Soc Nephrol; 2017 Oct; 12(10):1642-1651. PubMed ID: 28801527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Podocyte expression of human phospholipase A2 receptor 1 causes immune-mediated membranous nephropathy in mice.
    Tomas NM; Dehde S; Meyer-Schwesinger C; Huang M; Hermans-Borgmeyer I; Maybaum J; Lucas R; von der Heide JL; Kretz O; Köllner SMS; Seifert L; Huber TB; Zahner G
    Kidney Int; 2023 Feb; 103(2):297-303. PubMed ID: 36191868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of membranous nephropathy: a new paradigm in evolution.
    Glassock RJ
    Contrib Nephrol; 2013; 181():131-42. PubMed ID: 23689575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.